3 Biotech Gems to Stock Up on This Month Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at a few bargains in today’s choppy market. Source: BioSpace You Might Also Like AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study December 3, 2017 Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials February 7, 2018 MabVax Therapeutics Announces The Closing Of $1.3 Million Registered Direct Offering And Is Engaging An Advisory Bank To Explore Strategic Alternatives August 22, 2017
MabVax Therapeutics Announces The Closing Of $1.3 Million Registered Direct Offering And Is Engaging An Advisory Bank To Explore Strategic Alternatives August 22, 2017
